These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11954758

  • 1. Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.
    Latger-Cannard V, Marchand-Arvier M, Vidailhet M, Donadieu J, Vigneron C, Bordigoni P.
    Eur J Pediatr; 2002 Feb; 161(2):87-93. PubMed ID: 11954758
    [Abstract] [Full Text] [Related]

  • 2. Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib.
    Ishiguro A, Nakahata T, Shimbo T, Amano Y, Yasui K, Koike K, Komiyama A.
    Eur J Pediatr; 1993 Jan; 152(1):18-20. PubMed ID: 7680314
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ, Korchak HM, Douglas SD, Campbell DE, Thornton PS, Stanley CA, Baker L, Kilpatrick L.
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [Abstract] [Full Text] [Related]

  • 4. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
    Dale DC, Bolyard AA, Marrero T, Kelley ML, Makaryan V, Tran E, Leung J, Boxer LA, Kishnani PS, Austin S, Wanner C, Ferrecchia IA, Khalaf D, Maze D, Kurtzberg J, Zeidler C, Welte K, Weinstein DA.
    Curr Opin Hematol; 2019 Jan; 26(1):16-21. PubMed ID: 30451720
    [Abstract] [Full Text] [Related]

  • 5. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
    Schroten H, Roesler J, Breidenbach T, Wendel U, Elsner J, Schweitzer S, Zeidler C, Burdach S, Lohmann-Matthes ML, Wahn V.
    J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
    [Abstract] [Full Text] [Related]

  • 6. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
    Wortmann SB, Van Hove JLK, Derks TGJ, Chevalier N, Knight V, Koller A, Oussoren E, Mayr JA, van Spronsen FJ, Lagler FB, Gaughan S, Van Schaftingen E, Veiga-da-Cunha M.
    Blood; 2020 Aug 27; 136(9):1033-1043. PubMed ID: 32294159
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
    Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, Kurtzberg J.
    Blood; 2001 Jan 15; 97(2):376-82. PubMed ID: 11154211
    [Abstract] [Full Text] [Related]

  • 8. Effect of granulocyte-colony stimulating factor in glycogen storage disease type Ib.
    Zuccotti GV, Longhi R, Flumine P, Stangalini A, Riva E.
    J Int Med Res; 1993 Jan 15; 21(5):276-9. PubMed ID: 7509298
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.
    Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, Wendel U, Groenier KH, Smit GP.
    Eur J Pediatr; 2002 Oct 15; 161 Suppl 1():S83-7. PubMed ID: 12373578
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
    Wang WC, Crist WM, Ihle JN, Arnold BA, Keating JP.
    Leukemia; 1991 Apr 15; 5(4):347-9. PubMed ID: 1709246
    [Abstract] [Full Text] [Related]

  • 11. NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
    Piva E, De Toni S, Bovo C, Bordugo A, Burlina AB, Plebani M.
    Haematologica; 1996 Apr 15; 81(2):148-51. PubMed ID: 8641644
    [Abstract] [Full Text] [Related]

  • 12. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b.
    Lesma E, Riva E, Giovannini M, Di Giulio AM, Gorio A.
    Int J Immunopathol Pharmacol; 2005 Apr 15; 18(2):297-307. PubMed ID: 15888252
    [Abstract] [Full Text] [Related]

  • 13. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration.
    Kim GY, Lee YM, Kwon JH, Jun HS, Chou J.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):569-574. PubMed ID: 27864142
    [Abstract] [Full Text] [Related]

  • 14. Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function.
    Alsultan A, Sokol RJ, Lovell MA, Thurman G, Ambruso DR.
    Pediatr Blood Cancer; 2010 Dec 15; 55(7):1410-3. PubMed ID: 20830779
    [Abstract] [Full Text] [Related]

  • 15. Glycogen storage disease type Ib: infectious complications and measures for prevention.
    Wendel U, Schroten H, Burdach S, Wahn V.
    Eur J Pediatr; 1993 Dec 15; 152 Suppl 1():S49-51. PubMed ID: 7686491
    [Abstract] [Full Text] [Related]

  • 16. Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib.
    Letkemann R, Wittkowski H, Antonopoulos A, Podskabi T, Haslam SM, Föll D, Dell A, Marquardt T.
    Int Immunopharmacol; 2017 Mar 15; 44():216-225. PubMed ID: 28126686
    [Abstract] [Full Text] [Related]

  • 17. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
    Chen LY, Shieh JJ, Lin B, Pan CJ, Gao JL, Murphy PM, Roe TF, Moses S, Ward JM, Lee EJ, Westphal H, Mansfield BC, Chou JY.
    Hum Mol Genet; 2003 Oct 01; 12(19):2547-58. PubMed ID: 12925567
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory bowel disease in glycogen storage disease type Ib.
    Roe TF, Thomas DW, Gilsanz V, Isaacs H, Atkinson JB.
    J Pediatr; 1986 Jul 01; 109(1):55-9. PubMed ID: 3459848
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic enteritis in glycogen storage disease type IB with granulocyte colony-stimulating factor.
    Hoover EG, DuBois JJ, Samples TL, McCullough JS, Chenaille PJ, Montes RG.
    J Pediatr Gastroenterol Nutr; 1996 May 01; 22(4):346-50. PubMed ID: 8732896
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.
    Grünert SC, Derks TGJ, Adrian K, Al-Thihli K, Ballhausen D, Bidiuk J, Bordugo A, Boyer M, Bratkovic D, Brunner-Krainz M, Burlina A, Chakrapani A, Corpeleijn W, Cozens A, Dawson C, Dhamko H, Milosevic MD, Eiroa H, Finezilber Y, Moura de Souza CF, Garcia-Jiménez MC, Gasperini S, Haas D, Häberle J, Halligan R, Fung LH, Hörbe-Blindt A, Horka LM, Huemer M, Uçar SK, Kecman B, Kilavuz S, Kriván G, Lindner M, Lüsebrink N, Makrilakis K, Mei-Kwun Kwok A, Maier EM, Maiorana A, McCandless SE, Mitchell JJ, Mizumoto H, Mundy H, Ochoa C, Pierce K, Fraile PQ, Regier D, Rossi A, Santer R, Schuman HC, Sobieraj P, Spenger J, Spiegel R, Stepien KM, Tal G, Tanšek MZ, Torkar AD, Tchan M, Thyagu S, Schrier Vergano SA, Vucko E, Weinhold N, Zsidegh P, Wortmann SB.
    Genet Med; 2022 Aug 01; 24(8):1781-1788. PubMed ID: 35503103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.